TCM Biotech International Corp.
4169
Rank in Stocks
#15688
TCM Biotech International Corp., a biotech company, engages in the research and... TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Share Price
$3.69
Last synced: 2026-11-13
Market Cap
$245.02M
Change (1 day)
0.21%
Change (1 year)
-40.37%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TCM Biotech International Corp. (4169)
Category
Healthcare
EPS for TCM Biotech International Corp. (4169)
EPS as of June 2026 TTM: $-0.01
According to TCM Biotech International Corp.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $0.01, equal to its 2024 EPS of $0.01.
EPS history for TCM Biotech International Corp. from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -222.00% |
| 2025 | $0.01 | -7.27% |
| 2024 | $0.01 | -3.51% |
| 2023 | $0.01 | -5.79% |
| 2022 | $0.01 | 830.77% |
| 2021 | 0.00 | -92.86% |
| 2020 | $0.02 | 323.26% |
| 2019 | 0.00 | -72.96% |
| 2018 | $0.02 | 27.20% |
| 2017 | $0.01 | -39.61% |
| 2016 | $0.02 | 65.60% |
| 2015 | $0.01 | -31.32% |
| 2014 | $0.02 | 73.33% |
| 2013 | $0.01 | 9.38% |
| 2012 | $0.01 | 4.35% |
| 2011 | $0.01 | -324.39% |
| 2010 | 0.00 | -22.64% |
| 2009 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 7,195.08% |
US
|
|
| $15.66 | -128,460.66% |
US
|
|
| $-7.07 | 57,850.82% |
US
|
|
| $-5.29 | 43,260.66% |
AU
|
|
| $12.73 | -104,462.30% |
BE
|
Questions about TCM Biotech International Corp.'s earnings per share (EPS)
What is TCM Biotech International Corp.'s earnings per share (EPS)?
TCM Biotech International Corp.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was TCM Biotech International Corp.'s earnings per share (EPS) in 2025?
In 2025, TCM Biotech International Corp.'s earnings per share (EPS) was $0.01, about the same as in 2024 ($0.01).
How has TCM Biotech International Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, TCM Biotech International Corp.'s earnings per share (EPS) went from $0.02 to $0.01, an average decline of 12.94% a year.
How does TCM Biotech International Corp.'s earnings per share (EPS) compare with similar companies?
TCM Biotech International Corp.'s earnings per share (EPS) ($-0.01) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.